Clinical Trial Update: Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating the combination of talquetamab and lenalidomide as maintenance therapy after stem cell transplant in multiple myeloma; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Talquetamab (talquetamab)

Snippet

Sponsor: Stanford University | Conditions: Multiple Myeloma, Post Stem Cell Transplant | Phase 2 | Status: RECRUITING